Cargando…
Treatment of Parkinson’s disease in the advanced stage
Levodopa/Carbidopa, respectively, Levodopa/Benserazide is the most effective treatment for Parkinson’s disease and during the progress of the disease, patients will inevitably need to be treated with it. Nonetheless, after a certain time period most of the patients experience side effects. Mainly di...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611036/ https://www.ncbi.nlm.nih.gov/pubmed/23474822 http://dx.doi.org/10.1007/s00702-013-1008-y |
_version_ | 1782264528252174336 |
---|---|
author | Ossig, C. Reichmann, H. |
author_facet | Ossig, C. Reichmann, H. |
author_sort | Ossig, C. |
collection | PubMed |
description | Levodopa/Carbidopa, respectively, Levodopa/Benserazide is the most effective treatment for Parkinson’s disease and during the progress of the disease, patients will inevitably need to be treated with it. Nonetheless, after a certain time period most of the patients experience side effects. Mainly disturbing are motor and non-motor fluctuations and dyskinesia. Numerous options from changing the medication regimen, to continuos dopaminergic drug delivery via apomorphine or Duodopa pumps and stereotactical interventions are available. The physician’s responsibility is to choose the right therapeutic procedure for each timepoint of the patient’s disease. In this review, we provide an up to date overview of the available strategies. |
format | Online Article Text |
id | pubmed-3611036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-36110362013-04-01 Treatment of Parkinson’s disease in the advanced stage Ossig, C. Reichmann, H. J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Review Article Levodopa/Carbidopa, respectively, Levodopa/Benserazide is the most effective treatment for Parkinson’s disease and during the progress of the disease, patients will inevitably need to be treated with it. Nonetheless, after a certain time period most of the patients experience side effects. Mainly disturbing are motor and non-motor fluctuations and dyskinesia. Numerous options from changing the medication regimen, to continuos dopaminergic drug delivery via apomorphine or Duodopa pumps and stereotactical interventions are available. The physician’s responsibility is to choose the right therapeutic procedure for each timepoint of the patient’s disease. In this review, we provide an up to date overview of the available strategies. Springer Vienna 2013-03-10 2013 /pmc/articles/PMC3611036/ /pubmed/23474822 http://dx.doi.org/10.1007/s00702-013-1008-y Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Neurology and Preclinical Neurological Studies - Review Article Ossig, C. Reichmann, H. Treatment of Parkinson’s disease in the advanced stage |
title | Treatment of Parkinson’s disease in the advanced stage |
title_full | Treatment of Parkinson’s disease in the advanced stage |
title_fullStr | Treatment of Parkinson’s disease in the advanced stage |
title_full_unstemmed | Treatment of Parkinson’s disease in the advanced stage |
title_short | Treatment of Parkinson’s disease in the advanced stage |
title_sort | treatment of parkinson’s disease in the advanced stage |
topic | Neurology and Preclinical Neurological Studies - Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611036/ https://www.ncbi.nlm.nih.gov/pubmed/23474822 http://dx.doi.org/10.1007/s00702-013-1008-y |
work_keys_str_mv | AT ossigc treatmentofparkinsonsdiseaseintheadvancedstage AT reichmannh treatmentofparkinsonsdiseaseintheadvancedstage |